Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN) — Stella

Recruiting

Back to Metastatic Prostate Cancer trials

Trial locations(1 site)

China

Novartis Investigative Site, Shanghai, Shanghai Municipality

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~170 participants

Started

February 2026

Primary completion

August 2029

Age range

18 Years – 99 Years

Sex

Male only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov